Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lei Huo

Showing results (161-170 of 222) with videos related to

Pageof 23
Sort By:
Cancer Management and Research|September 5, 2020
Adverse Factors of Treatment Response and Overall Survival in Pediatric and Adult Patients with PineoblastomaXu-Lei Huo, Bo Wang, Gui-Jun Zhang, et al.
Cancer|February 11, 2014
Primary tumor resection as a component of multimodality treatment may improve local control and survival in patients with stage IV inflammatory breast cancerCatherine L Akay, Naoto T Ueno, Gary B Chisholm, et al.
Clinical Breast Cancer|March 6, 2023
Breast Cancer With a HER2 FISH Group 2 Result: Should HER2 Tests be Repeated?Minhua Wang, Qingqing Ding, Jun Gu, et al.
Human Pathology|November 22, 2020
Comparison of three FDA-approved diagnostic immunohistochemistry assays of PD-L1 in triple-negative breast carcinomaXiao Huang, Qingqing Ding, Hua Guo, et al.
Human Pathology|July 31, 2014
Molecular cytogenetic characterization of mammary neuroendocrine carcinomaDe-Bing Xiang, Bing Wei, Susan C Abraham, et al.
Cancer|July 14, 2023
The association of carbohydrate antigen 19-9 response with radiologic response and survival in intrahepatic cholangiocarcinoma: A prospective cohort studyQuan-Yu Cai, Ping Yang, Xiao-Liang Yang, et al.
Breast Cancer Research : BCR|June 25, 2020
Comparison of three scoring methods using the FDA-approved 22C3 immunohistochemistry assay to evaluate PD-L1 expression in breast cancer and their association with clinicopathologic factorsHua Guo, Qingqing Ding, Yun Gong, et al.
Leukemia Research|March 5, 2019
The value of FDP/FIB and D-dimer/FIB ratios in predicting high-risk APL-related thrombosisYanliang Bai, Mingyue Shi, Xiawan Yang, et al.
Cancer|June 22, 2010
Histologic changes associated with false-negative sentinel lymph nodes after preoperative chemotherapy in patients with confirmed lymph node-positive breast cancer before treatmentAlexandra S Brown, Kelly K Hunt, Jeannie Shen, et al.
Frontiers in Oncology|September 28, 2020
MicroRNA-221/222 Inhibits the Radiation-Induced Invasiveness and Promotes the Radiosensitivity of Malignant Meningioma CellsQing Zhang, Lai-Rong Song, Xu-Lei Huo, et al.
Pageof 23

Showing results (161-170 of 222) with videos related to

Sort By:
Pageof 23
Cancer Management and Research|September 5, 2020
Adverse Factors of Treatment Response and Overall Survival in Pediatric and Adult Patients with PineoblastomaXu-Lei Huo, Bo Wang, Gui-Jun Zhang, et al.
Cancer|February 11, 2014
Primary tumor resection as a component of multimodality treatment may improve local control and survival in patients with stage IV inflammatory breast cancerCatherine L Akay, Naoto T Ueno, Gary B Chisholm, et al.
Clinical Breast Cancer|March 6, 2023
Breast Cancer With a HER2 FISH Group 2 Result: Should HER2 Tests be Repeated?Minhua Wang, Qingqing Ding, Jun Gu, et al.
Human Pathology|November 22, 2020
Comparison of three FDA-approved diagnostic immunohistochemistry assays of PD-L1 in triple-negative breast carcinomaXiao Huang, Qingqing Ding, Hua Guo, et al.
Human Pathology|July 31, 2014
Molecular cytogenetic characterization of mammary neuroendocrine carcinomaDe-Bing Xiang, Bing Wei, Susan C Abraham, et al.
Cancer|July 14, 2023
The association of carbohydrate antigen 19-9 response with radiologic response and survival in intrahepatic cholangiocarcinoma: A prospective cohort studyQuan-Yu Cai, Ping Yang, Xiao-Liang Yang, et al.
Breast Cancer Research : BCR|June 25, 2020
Comparison of three scoring methods using the FDA-approved 22C3 immunohistochemistry assay to evaluate PD-L1 expression in breast cancer and their association with clinicopathologic factorsHua Guo, Qingqing Ding, Yun Gong, et al.
Leukemia Research|March 5, 2019
The value of FDP/FIB and D-dimer/FIB ratios in predicting high-risk APL-related thrombosisYanliang Bai, Mingyue Shi, Xiawan Yang, et al.
Cancer|June 22, 2010
Histologic changes associated with false-negative sentinel lymph nodes after preoperative chemotherapy in patients with confirmed lymph node-positive breast cancer before treatmentAlexandra S Brown, Kelly K Hunt, Jeannie Shen, et al.
Frontiers in Oncology|September 28, 2020
MicroRNA-221/222 Inhibits the Radiation-Induced Invasiveness and Promotes the Radiosensitivity of Malignant Meningioma CellsQing Zhang, Lai-Rong Song, Xu-Lei Huo, et al.
Pageof 23